Risk Factors for Adrenal Invasion in Renal Cell Carcinoma

• Kaan Çömez
• Serdar Çelik
• Ozan Bozkurt
• Ömer Demir
• Güven Aslan
• Kutsal Yörükoğlu
• İlhan Çelebi

Long-Term Outcomes of Patients Who Underwent Ureterocutaneostomy

• Fuat Kızılay
• Adnan Şimşir
• İbrahim Cüreklibatır
• Çağ Çal

A Rare Tumor: Small Cell Prostate Carcinoma Case Report

• Mehmet Erhan Aydın
• Deniz Bolat
• Funda Taşlı
• Tansu Değirmenci
• Bülent Günlüsoy

2017 Author Index

The Effect of Transrectal Ultrasound-guided Prostate Needle Biopsy on Lower Urinary Tract Symptoms

• Volkan Çağlayan
• Sedat Öner
• Efe Önen
• Sinan Avcı
• Mustafa Murat Aydos
• Murat Demirbaş

Gleason Score Correlation Between Prostate Biopsy and Radical Prostatectomy Specimens

• Erdem Öztürk
• Taha Numan Yıkılmaz

Evaluation of General Characteristics of Renal Cell Carcinoma Patients: A Single Center Experience

• Ümmügül Üyetürk
• Tuba Taslamacıoğlu Duman
• Burak Yılmaz
• Nadire Küçüköztaş
• Uğur Üyetürk

What is the Prostate-Specific Antigen Cut-Off Value to Detect Clinically Significant Prostate Cancer According to Age in Turkey?

• Turgay Ebiloğlu
• Engin Kaya

Organ-Preserving Approach in Bladder Cancer: Assessment of the Current Situation

• Reha Girgin
• N. Aydın Mungan

Positron Emission Tomography in Renal Cell Carcinoma

• Cigdem Soydal
• Yüksel Ürün

Contemporary Trends in Adjuvant and Neoadjuvant Treatment for Renal Cell Carcinoma

• Kamil Çam

Incidentally Found Paratesticular Rhabdomyosarcoma: Case Report

• Halil Çağrı Aybal
• Taha Numan Yıkılmaz
• Fatih Hızlı
• Halil Başar
• Emin Taha Keskin

Active Surveillance in Prostate Cancer

• Volkan İzol
• Nebil Akdoğan

Assessment of the Relationship Between Serum Prostate-Specific Antigen Level and Serum Fasting Glucose, Total Cholesterol and Neutrophil-Lymphocyte Ratio in Men Aged 50-70 Years with Prostate-Specific Antigen Level 0-10 ng/mL without Prostate Cancer Diagnosis

• Bora İrer

Wunderlich Syndrome, Tuberous Sclerosis-Related Giant Renal Angiomyolipoma Rupture: Case Report

• Özer Baran
• Aykut Aykaç
• Serkan Öner
• Alpay Aktümen
• Salih Bürlukkara
• Mehmet Melih Sunay
• Hakkı Uğur Özok

Limited-standard-extended lymphadenectomy in bladder cancer

• Hayrettin Şahin

Experimental animal models for bladder cancer

• Şevket Tolga Tombul
• Talha Müezzinoğlu

Radiation therapy for bladder cancer

• Ömür Karakoyun Çelik
• Fatma Sert

Radical Cystectomy in Elderly Patients: Predicting Complications and Mortality, Technical Aspects and Postoperative Care

• Uğur Kuyumcuoğlu
• Kaan Özdedeli

Evaluation of the Current Situation Tissue and Serum Biomarkers in Prostate Cancer

• Enis Kervancıoğlu
• Murat Koşan

Active Surveillance-Factors Affecting the Treatment Decision: 3M: “Marker”, “Mapping”, “MRI”

• Ender Özden
• Mehmet Necmettin Mercimek

Evaluation of Role of Inflammatory Markers for the Prediction of Recurrence on Pathologic T1a Clear Cell Renal Cell Cancer Patients

• Mehmet İlker Gökçe
• Nurullah Hamidi
• Barış Esen
• Semih Tangal
• Evren Süer
• Sümer Baltacı

A Rare Case: Contralateral Testicular Seminoma Accompanied by Right Undescended Testicle and Right Inguinal Hernia with Ipsilateral Renal Agenesis and Seminal Vesicle Agenesis

• Zafer Demirer
• Ali Gürağaç
• Sami Uğuz
• Bilal Fırat Alp
• İbrahim Yıldırım

The Efficiency of Docetaxel Chemotherapy on Castration Resistant Prostate Cancer: Singe Center Experience

• Evren Süer
• Nurullah Hamidi
• Mehmet İlker Gökçe
• Sümer Baltacı

Comparison of Subcapsular and Total Orchiectomy in Patients with Prostate Cancer

• Taha Numan Yıkılmaz
• Erdem Öztürk
• Nurullah Hamidi
• Halil Başar

Predictive Value of Hormonal Evaluation Before Prostate Needle Biopsy on Prostate Cancer T Stage and Prognosis

• Serdar Çelik
• Ozan Bozkurt
• Hüseyin Alperen Yıldız
• Ömer Demir
• Burçin Tuna
• Kutsal Yörükoğlu
• Güven Aslan

Effects and Mechanisms of Checkpoint Inhibitors (CTLA-4, PD-1 and PD-L1 Inhibitors) as New Immunotherapeutic Agents for Bladder Cancer

• Serdar Çelik
• Zekiye Sultan Altun
• Safiye Aktaş

Metastasis Targeted Therapies in Renal Cell Cancer

• K. Fehmi Narter
• Bora Özveren

Reflection of Adjuvant Treatment Approaches for Early Stage Testis Tumors in Our Clinic

• İsmail Selvi
• Erdem Öztürk
• Taha Numan Yıkılmaz
• Nurullah Hamidi
• Halil Başar

Oncocytic Adrenocortical Carcinoma: A Rare Case Report

• Oktay Üçer
• Oğuzcan Erbatu
• Ayça Tan
• Talha Müezzinoğlu

Analysis of Factors Affecting Functional Outcomes in Robotic-assisted Laparoscopic Radical Prostatectomy

• Fuat Kızılay
• Fuad İsmaylov
• Adnan Şimşir
• Burak Turna
• Bülent Semerci
• Erdal Apaydın

Granulomatous Prostatitis: Case Report and Review of the Literature

• Meriç Doğan Güven
• Taha Numan Yıkılmaz
• Erdem Öztürk
• Halil Başar

Socioeconomic Predictors and Patient Perspectives of Prostate-specific Antigen Testing

• Bora İrer

Prostate cancer: New developments in pathogenesis and prognostic repercussions

• Bora Gürel

Evaluation of the non-neoplastic kidney in tumor nephrectomy specimens and its significance

• Ayşim Özağarı

Testicular cancers: developments in radiotherapy

• Şefik İğdem
• Gül Alço

Geometry of cancer and fractals in bladder cancer

• Fehmi Narter
• Osman Köse

Bladder cancer and genetics

• Ata Özen
• Cavit Can

Editorial

• Talha Müezzinoglu

Robot-assisted partial nephrectomy: step by step

• Alper Bitkin
• Volkan Tugcu

Open partial nephrectomy: recent situation

• İyimser Üre
• Sinan Sözen

Hemostatic agents in open partial nephrectomy

• Kemal Ener
• Emrah Okulu
• Önder Kayıgil

Nomograms for prostate cancer: which and when to use

• Saadettin Eskiçorapçı
• Deniz Bolat

What is the best cutoff value of PSA in detection of prostate cancer

• Hakan Gemalmaz

Current treatment approaches in locally advanced prostate cancer: a radiation oncologist perspective

• Ömür Karakoyun Çelik

Bladder cancer epidemiology in the world and in Tukey

• Sultan Eser
• Raziye Özdemir

The approaches in uncommon malignant tumours of the bladder

• Hayrettin Şahin

Approach to the complications of intravesical therapy in bladder cancer

• Turgay Gülecen
• Cüneyd Özkürkçügil

New approaches to assess the morphology of renal masses

• Barbaros Başeskioğlu
• Cavit Can

Management of post-chemotherapy residual masses in testicular tumor and surgical tecnique

• Ferhat Ateş
• Ömer Yılmaz
• Kadir Vehbi Baykal